EXICURE, INC. Cash and Cash Equivalents
EXICURE, INC. (XCUR) had Cash and Cash Equivalents of $4.44 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2025-11-07
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $4.44M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $7.86M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $10.42M.
- 2024-12-31: Cash and Cash Equivalents, at Carrying Value $12.51M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2025-09-30 | $4.44M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $7.86M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.42M 10-Q · filed 2025-06-27 |
| 2024-12-31 | $12.51M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $343.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $528.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $366.00K 10-Q · filed 2024-06-17 |
| 2023-12-31 | $816.00K 10-Q · filed 2024-11-14 |
| 2023-09-30 | $922.00K 10-Q · filed 2024-05-16 |
| 2023-06-30 | $2.33M 10-Q/A · filed 2024-06-06 |
| 2023-03-31 | $9.96M 10-Q/A · filed 2024-06-06 |
| 2022-12-31 | $8.58M 10-Q/A · filed 2024-06-06 |
| 2022-09-30 | $15.65M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $21.20M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $23.89M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $34.64M 10-K · filed 2023-03-27 |
| 2021-09-30 | $51.88M 10-Q · filed 2021-11-19 |
| 2021-06-30 | $42.59M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $34.30M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $33.26M 10-K · filed 2022-03-25 |
| 2020-09-30 | $31.46M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $17.20M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $24.58M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $48.46M 10-K · filed 2021-03-11 |
| 2019-09-30 | $70.39M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $17.18M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $22.20M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $26.27M 10-Q · filed 2019-11-07 |
| 2018-09-30 | $32.45M 10-Q · filed 2019-11-07 |
| 2018-06-30 | $16.38M 10-Q · filed 2019-08-08 |
| 2018-03-31 | $21.12M 10-Q · filed 2019-05-08 |
| 2017-12-31 | $25.76M 10-Q · filed 2019-11-07 |
| 2017-09-30 | $22.94M 10-Q · filed 2018-11-06 |
| 2017-08-31 | $1.54K 10-Q · filed 2017-09-12 |
| 2017-06-30 | $8.83M 10-Q · filed 2018-08-06 |
| 2017-05-31 | $7.19K 10-Q · filed 2017-07-11 |
| 2017-03-31 | $12.42M 10-Q · filed 2018-05-15 |
| 2017-02-28 | $6.03K 10-Q · filed 2017-09-12 |
| 2016-12-31 | $19.62M 10-K/A · filed 2019-09-23 |
| 2016-09-30 | $14.07M 10-Q · filed 2017-11-14 |
| 2015-12-31 | $18.73M 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |